SCHEMBL3814534

SCHEMBL3814534

CSc1nccc(C(Cc2cccc(C#N)c2)(c2cccnc2)c2cccnc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.40
ALDH1A1 P00352 6/20 0.40
CYP1A2 P05177 5/20 0.40
HSD17B10 Q99714 5/20 0.40
CYP2C19 P33261 4/20 0.40
CLK4 Q9HAZ1 4/20 0.40
MAPK1 P28482 3/20 0.40
ALOX15 P16050 2/20 0.40
TSHR P16473 2/20 0.40
VNN1 O95497 2/20 0.36
SGMS2 Q8NHU3 2/20 0.35
NAMPT P43490 1/20 0.35
CYP19A1 P11511 2/20 0.34
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
MEN1 O00255 2/20 0.34
CYP2C9 P11712 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3810699 0.85 ALDH1A1 (0.41) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL1378899 0.83 TLR7 (0.39) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL3819160 0.82 CYP3A4 (0.39) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL1378654 0.82 CYP3A4 (0.39) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL3814300 0.82 CHRNB2 (0.39) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL1380977 0.76 CYP3A4 (0.41) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL1379190 0.74 CYP3A4 (0.39) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL1378285 0.72 CYP3A4 (0.41) CYP3A4ALDH1A1CYP1A2CYP2C19CYP19A1
SCHEMBL4184873 0.72 CYP3A4 (0.44) CYP3A4ALDH1A1CYP1A2HSD17B10CYP2C19
SCHEMBL1377553 0.70 DYRK3 (0.34) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP disclosed
WO-2006028590-A1 1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-03-16 WO disclosed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed